Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
31
Frequently Asked Questions
What is Market Cap of Scinai Immunotherapeutics Ltd - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Scinai Immunotherapeutics Ltd - ADR market cap is $1.26M.
What is the 52-week high for Scinai Immunotherapeutics Ltd - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Scinai Immunotherapeutics Ltd - ADR 52 week high is $6.18 as of October 10, 2025.
What is the 52-week low for Scinai Immunotherapeutics Ltd - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Scinai Immunotherapeutics Ltd - ADR 52 week low is $1.20 as of October 10, 2025.
What is Scinai Immunotherapeutics Ltd - ADR stock price today?
Scinai Immunotherapeutics Ltd - ADR stock price today is $1.50.
What was Scinai Immunotherapeutics Ltd - ADR stock price yesterday?
Scinai Immunotherapeutics Ltd - ADR stock price yesterday was $1.48.
What is the PE ratio of Scinai Immunotherapeutics Ltd - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Scinai Immunotherapeutics Ltd - ADR’s P/E ratio is 0.30.
What is the Price-to-Book ratio of Scinai Immunotherapeutics Ltd - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Scinai Immunotherapeutics Ltd - ADR P/B ratio is 0.2902.
What is the 50-day moving average of Scinai Immunotherapeutics Ltd - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Scinai Immunotherapeutics Ltd - ADR 50-day moving average is $1.51.
How many employess does Scinai Immunotherapeutics Ltd - ADR has?
Scinai Immunotherapeutics Ltd - ADR has 31 employees.